Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Paola, Tacchetti"'
Autor:
Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 485-493 (2024)
Abstract Belantamab mafodotin is the first‐in‐class antibody‐drug conjugates targeting B‐cell maturation antigen to have demonstrated effectiveness in triple‐class refractory multiple myeloma (TCR‐MM) patients. We performed a retrospectiv
Externí odkaz:
https://doaj.org/article/7725cc7a33b84acb8c1ed168063ccd72
Autor:
Carolina Terragna, Andrea Poletti, Vincenza Solli, Marina Martello, Elena Zamagni, Lucia Pantani, Enrica Borsi, Ilaria Vigliotta, Gaia Mazzocchetti, Silvia Armuzzi, Barbara Taurisano, Nicoletta Testoni, Giulia Marzocchi, Ajsi Kanapari, Ignazia Pistis, Paola Tacchetti, Katia Mancuso, Serena Rocchi, Ilaria Rizzello, Michele Cavo
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract The complexity of Multiple Myeloma (MM) is driven by several genomic aberrations, interacting with disease-related and/or -unrelated factors and conditioning patients’ clinical outcome. Patient’s prognosis is hardly predictable, as commo
Externí odkaz:
https://doaj.org/article/b0670f38bd1042f68b22b11a9e85ac10
Autor:
Flavia Bigi, Paola Tacchetti, Alessandro Giorgi, Gaia Mazzocchetti, Vincenza Solli, Simona Barbato, Barbara Sinigaglia, Elena Campanini, Emanuele Favero, Marco Talarico, Michele Puppi, Ilaria Rizzello, Serena Rocchi, Katia Mancuso, Lucia Pantani, Michele Cavo, Elena Zamagni
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
The impact of daratumumab on CD34+ hematopoietic stem cell (HSC) mobilization has recently been a matter of concern. To address this issue, we compared CD34+ HSC-related outcomes in patients with multiple myeloma treated with daratumumab-based quadru
Externí odkaz:
https://doaj.org/article/950b5b65be544c078de9b75b3a23a37d
Autor:
Flavia Bigi, Enrica Manzato, Simona Barbato, Marco Talarico, Michele Puppi, Simone Masci, Ilaria Sacchetti, Roberta Restuccia, Miriam Iezza, Ilaria Rizzello, Chiara Sartor, Katia Mancuso, Lucia Pantani, Paola Tacchetti, Michele Cavo, Elena Zamagni
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 944 (2024)
This systematic review examines the available clinical data on CD34+ cell mobilization, collection, and engraftment in multiple myeloma patients treated with the anti-CD38 monoclonal antibodies daratumumab and isatuximab in clinical trials and in rea
Externí odkaz:
https://doaj.org/article/ca8c80232cb64f9c9adf1c517eb96ad0
Autor:
Enrica Borsi, Ilaria Vigliotta, Andrea Poletti, Gaia Mazzocchetti, Vincenza Solli, Luca Zazzeroni, Marina Martello, Silvia Armuzzi, Barbara Taurisano, Ajsi Kanapari, Ignazia Pistis, Elena Zamagni, Lucia Pantani, Serena Rocchi, Katia Mancuso, Paola Tacchetti, Ilaria Rizzello, Simonetta Rizzi, Elisa Dan, Barbara Sinigaglia, Michele Cavo, Carolina Terragna
Publikováno v:
Cells, Vol 13, Iss 8, p 657 (2024)
Clonal hematopoiesis of indeterminate potential (CHIP) refers to the phenomenon where a hematopoietic stem cell acquires fitness-increasing mutation(s), resulting in its clonal expansion. CHIP is frequently observed in multiple myeloma (MM) patients,
Externí odkaz:
https://doaj.org/article/9eb6935ac05845519040d5dd9482e687
Autor:
Katia Mancuso, Elena Zamagni, Vincenza Solli, Liliana Gabrielli, Marta Leone, Lucia Pantani, Serena Rocchi, Ilaria Rizzello, Paola Tacchetti, Stefano Ghibellini, Emanuele Favero, Margherita Ursi, Marco Talarico, Simona Barbato, Ajsi Kanapari, Flavia Bigi, Michele Puppi, Carolina Terragna, Enrica Borsi, Marina Martello, Andrea Poletti, Alessandra Scatà, Giuliana Nepoti, Barbara Ruffini, Tiziana Lazzarotto, Michele Cavo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Long-term kinetics of antibody (Ab) and cell-mediated immune (CMI) response to full anti-SARS-CoV-2 vaccine schedule and booster doses in Multiple Myeloma (MM) patients remain unclear. We prospectively evaluated Ab and CMI response to mRNA vaccines i
Externí odkaz:
https://doaj.org/article/6db24e4256444d06bdb7d131755a0f29
Autor:
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota-Scalabrini, Francesca Bonello, Caterina Musolino, Michele Cea, Renato Zambello, Paola Tacchetti, Angelo Belotti, Claudia Cellini, Laura Paris, Mariella Grasso, Sara Aquino, Lorenzo De Paoli, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Mario Boccadoro, Federico Monaco, Paolo Corradini, Alessandra Larocca
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/85d07ceb4ffb4350a7da29ebc2f8331e
Autor:
Ilaria Vigliotta, Silvia Armuzzi, Martina Barone, Vincenza Solli, Ignazia Pistis, Enrica Borsi, Barbara Taurisano, Gaia Mazzocchetti, Marina Martello, Andrea Poletti, Chiara Sartor, Ilaria Rizzello, Lucia Pantani, Paola Tacchetti, Cristina Papayannidis, Katia Mancuso, Serena Rocchi, Elena Zamagni, Antonio Curti, Mario Arpinati, Michele Cavo, Carolina Terragna
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionMinimal residual disease (MRD) is commonly assessed in bone marrow (BM) aspirate. However, sample quality can impair the MRD measurement, leading to underestimated residual cells and to false negative results. To define a reliable and rep
Externí odkaz:
https://doaj.org/article/45f876f6faa8455682afb6ec6aa42bb9
Autor:
Fortunato Morabito, Elena Zamagni, Concetta Conticello, Vincenzo Pavone, Salvatore Palmieri, Sara Bringhen, Monica Galli, Silvia Mangiacavalli, Daniele Derudas, Elena Rossi, Roberto Ria, Lucio Catalano, Paola Tacchetti, Giuseppe Mele, Iolanda Donatella Vincelli, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Francesco Mendicino, Cirino Botta, Anna Mele, Lucia Pantani, Serena Rocchi, Bruno Garibaldi, Nicola Cascavilla, Stelvio Ballanti, Giovanni Tripepi, Ferdinando Frigeri, Antonetta Pia Falcone, Clotilde Cangialosi, Giovanni Reddiconto, Giuliana Farina, Marialucia Barone, Ilaria Rizzello, Enrico Iaccino, Selena Mimmi, Paola Curci, Barbara Gamberi, Pellegrino Musto, Valerio De Stefano, Maurizio Musso, Maria Teresa Petrucci, Massimo Offidani, Francesco Di Raimondo, Mario Boccadoro, Michele Cavo, Antonino Neri, Massimo Gentile
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The present study aimed to develop two survival risk scores (RS) for overall survival (OS, SRSKRd/EloRd) and progression-free survival (PFS, PRSKRd/EloRd) in 919 relapsed/refractory multiple myeloma (RRMM) patients who received carfilzomib, lenalidom
Externí odkaz:
https://doaj.org/article/558f55d38b4c4a8a985194fbba17f62d
Autor:
Marika Pane, Giorgia Coratti, Valeria A. Sansone, Sonia Messina, Michela Catteruccia, Claudio Bruno, Maria Sframeli, Emilio Albamonte, Marina Pedemonte, Adele D’Amico, Chiara Bravetti, Beatrice Berti, Concetta Palermo, Daniela Leone, Giorgia Brigati, Paola Tacchetti, Francesca Salmin, Roberto De Sanctis, Simona Lucibello, Maria Carmela Pera, Marco Piastra, Orazio Genovese, Enrico Bertini, Gianluca Vita, Francesco Danilo Tiziano, Eugenio Mercuri, the Italian EAP Working Group
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 3, Pp 548-557 (2021)
Abstract Objective The aim of this paper was to report the 2‐year follow‐up in type I patients treated with Nusinersen and to assess whether possible changes in motor function are related to the subtype, age, or SMN2 copy number. Methods Sixty‐
Externí odkaz:
https://doaj.org/article/21f37327eb0f4e088a3f71a02ca0497d